{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:22:34Z","timestamp":1793197354085,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016542","name":"Progenics Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19450"],"award-info":[{"award-number":["21K19450"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.semnuclmed.2021.12.003","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T12:30:11Z","timestamp":1642595411000},"page":"406-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["SPECT and PET Radiotracers in Renal Imaging"],"prefix":"10.1053","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-6046","authenticated-orcid":false,"given":"Rudolf A.","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-7835","authenticated-orcid":false,"given":"Takahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM196512232732603","article-title":"The scintigram after renal transplantation in man","volume":"273","author":"Figueroa","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0002","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2967\/jnumed.113.133454","article-title":"Radionuclides in nephrourology, Part 2: Pitfalls and diagnostic applications","volume":"55","author":"Taylor","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0003","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2967\/jnumed.113.133447","article-title":"Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices","volume":"55","author":"Taylor","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0004","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1007\/s00259-019-04485-3","article-title":"EANM procedure guidelines for radionuclide therapy with (177)Lu-labelled PSMA-ligands ((177)Lu-PSMA-RLT)","volume":"46","author":"Kratochwil","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0005","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","article-title":"The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours","volume":"40","author":"Bodei","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0006","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2967\/jnumed.117.193037","article-title":"Integrating MRI and chemokine receptor CXCR4-Targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation","volume":"58","author":"Derlin","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0007","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1021\/acsomega.8b01885","article-title":"Novel (18)F-Labeled PET Imaging Agent FV45 targeting the renin-angiotensin system","volume":"3","author":"Chen","year":"2018","journal-title":"ACS Omega"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0008","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.kint.2020.02.024","article-title":"Positron emission tomography imaging of renal mitochondria is a powerful tool in the study of acute and progressive kidney disease models","volume":"98","author":"Saeki","year":"2020","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0009","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.7150\/thno.61423","article-title":"Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction","volume":"11","author":"Werner","year":"2021","journal-title":"Theranostics"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/j.semnuclmed.2018.02.010","article-title":"SNMMI procedure standard\/EANM practice guideline for diuretic renal scintigraphy in adults with suspected upper urinary tract obstruction 1.0","volume":"48","author":"Taylor","year":"2018","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s002400050136","article-title":"Obstructive uropathy vs nephropathy: Compartmental analysis in radioisotopic renography as a new methodology","volume":"27","author":"Barbalias","year":"1999","journal-title":"Urol Res"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0012","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.mcna.2017.10.013","article-title":"Urologic Emergencies","volume":"102","author":"Manjunath","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0013","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-018-4129-6","article-title":"The SNMMI and EANM practice guideline for renal scintigraphy in adults","volume":"45","author":"Blaufox","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0014","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-019-04359-8","article-title":"The next era of renal radionuclide imaging: Novel PET radiotracers","volume":"46","author":"Werner","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 Trial of (177)Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0016","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[(177)Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0017","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2021.12.003_bib0018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/pros.24250","article-title":"Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapy","volume":"82","author":"Widjaja","year":"2022","journal-title":"Prostate"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0019","doi-asserted-by":"crossref","first-page":"41233","DOI":"10.18632\/oncotarget.9775","article-title":"The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy","volume":"7","author":"Werner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10554-018-1469-z","article-title":"Moving into the next era of PET myocardial perfusion imaging: Introduction of novel (18)F-labeled tracers","volume":"35","author":"Werner","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/RLU.0000000000000670","article-title":"Initial experience using 99mTc-MIBI SPECT\/CT for the differentiation of oncocytoma from renal cell carcinoma","volume":"40","author":"Rowe","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2015.08.056","article-title":"Prospective Evaluation of (99m)Tc-sestamibi SPECT\/CT for the diagnosis of renal oncocytomas and hybrid oncocytic\/chromophobe tumors","volume":"69","author":"Gorin","year":"2016","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0023","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/RLU.0000000000001534","article-title":"Defining the added value of 99mTc-MIBI SPECT\/CT to conventional cross-sectional imaging in the characterization of enhancing solid renal masses","volume":"42","author":"Sheikhbahaei","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12149-017-1222-z","article-title":"Use of quantitative SPECT\/CT reconstruction in (99m)Tc-sestamibi imaging of patients with renal masses","volume":"32","author":"Jones","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0025","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S1470-2045(21)00540-4","article-title":"Nuclear medicine theranostics comes of age","volume":"22","author":"Herrmann","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0026","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.semnuclmed.2016.04.002","article-title":"Gallium-68 EDTA PET\/CT for renal imaging","volume":"46","author":"Hofman","year":"2016","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0027","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2967\/jnumed.115.154757","article-title":"Impact of point-spread function modeling on pet image quality in integrated PET\/MR hybrid imaging","volume":"57","author":"Aklan","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0028","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2967\/jnumed.119.240440","article-title":"The changing face of nuclear cardiology: Guiding cardiovascular care toward molecular medicine","volume":"61","author":"Werner","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/RLU.0000000000002494","article-title":"Novel functional renal PET imaging with 18F-FDS in human subjects","volume":"44","author":"Werner","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0030","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2967\/jnumed.119.239806","article-title":"(11)C-PABA as a PET radiotracer for functional renal imaging: Preclinical and first-in-human study","volume":"61","author":"Ruiz-Bedoya","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semnuclmed.2007.09.008","article-title":"Radiopharmaceuticals for renal positron emission tomography imaging","volume":"38","author":"Szabo","year":"2008","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0032","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2967\/jnumed.116.172718","article-title":"Initial preclinical evaluation of 18F-Fluorodeoxysorbitol PET as a novel functional renal imaging agent","volume":"57","author":"Wakabayashi","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0033","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2967\/jnumed.117.203828","article-title":"Functional renal imaging with 2-Deoxy-2-(18)F-Fluorosorbitol PET in rat models of renal disorders","volume":"59","author":"Werner","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0034","doi-asserted-by":"crossref","first-page":"5274-52,86","DOI":"10.1038\/s41596-021-00613-2","article-title":"Kit-based synthesis of 2-deoxy-2-[(18)F]-fluoro-D-sorbitol for bacterial imaging","volume":"16","author":"Mota","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jlcr.3887","article-title":"Facile synthesis of 2-deoxy-2-[(18) F]fluorosorbitol using sodium borohydride on aluminum oxide","volume":"64","author":"Hasegawa","year":"2021","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0036","first-page":"249","article-title":"Determination of split renal function by PSMA imaging: Comparison of (68)Ga-PSMA-11 PET with (99m)Tc-MAG3 scintigraphy","volume":"10","author":"Rosar","year":"2020","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2019.08.004","article-title":"PET [(11)C]acetate is also a perfusion tracer for kidney evaluation purposes","volume":"76-77","author":"Normand","year":"2019","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nucmedbio.2017.12.001","article-title":"Re(CO)3([(18)F]FEDA), a novel (18)F PET renal tracer: Radiosynthesis and preclinical evaluation","volume":"58","author":"Lipowska","year":"2018","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0001-2998(05)80174-6","article-title":"99mTc renal tubular function agents: Current status","volume":"20","author":"Eshima","year":"1990","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13550-018-0389-1","article-title":"Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET\/MRI in healthy subjects","volume":"8","author":"Geist","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0041","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.semnephrol.2011.05.008","article-title":"Positron emission tomography (PET) assessment of renal perfusion","volume":"31","author":"Green","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0042","first-page":"470","article-title":"Mapping of local renal blood flow with PET and H(2)(15)O","volume":"43","author":"Alpert","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0043","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00259-012-2082-3","article-title":"Quantification of myocardial blood flow with 82Rb positron emission tomography: Clinical validation with 15O-water","volume":"39","author":"Prior","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0044","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2967\/jnumed.110.077669","article-title":"Human biodistribution and radiation dosimetry of 82Rb","volume":"51","author":"Senthamizhchelvan","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2967\/jnumed.104.007831","article-title":"Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: Comparison with (13)N-ammonia PET","volume":"50","author":"El Fakhri","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0046","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ki.1993.340","article-title":"Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis","volume":"44","author":"Nitzsche","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0047","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nucmedbio.2007.01.002","article-title":"Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion","volume":"34","author":"Green","year":"2007","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0048","first-page":"146","article-title":"Evaluation of 62Cu-ETS as a PET tracer of renal perfusion in a porcine model of acute focal renal injury","volume":"47","author":"Green","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0049","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/S0895-7061(99)00248-4","article-title":"Renal responses to AT1 receptor blockade","volume":"13","author":"Navar","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.semnuclmed.2010.09.003","article-title":"Molecular imaging of the kidneys","volume":"41","author":"Szabo","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0051","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/HYPERTENSIONAHA.107.102715","article-title":"Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis","volume":"51","author":"Xia","year":"2008","journal-title":"Hypertension"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0052","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.HYP.0000022060.13995.ED","article-title":"Differential regulation of elevated renal angiotensin II in chronic renal ischemia","volume":"40","author":"Tokuyama","year":"2002","journal-title":"Hypertension"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0053","unstructured":"Hwang DR, Eckelman WC, Mathias CJ, et al: Positron-labeled angiotensin-converting enzyme (ACE) inhibitor: Fluorine-18-fluorocaptopril. Probing the ACE activity in vivo by positron emission tomography. J Nucl Med 32:1730-1737, 199"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0054","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bmc.2003.10.054","article-title":"11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat","volume":"12","author":"Matarrese","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0055","first-page":"1595","article-title":"Carbon-11-acetate PET imaging in renal disease","volume":"36","author":"Shreve","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0056","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.kint.2020.03.021","article-title":"Visualizing mitochondrial (dys)function using positron emission tomography imaging","volume":"98","author":"Srivastava","year":"2020","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0057","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","article-title":"Mitochondrial dysfunction in the pathophysiology of renal diseases","volume":"306","author":"Che","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0058","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ehjci\/jey119","article-title":"Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis","volume":"20","author":"Werner","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0059","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2967\/jnumed.119.237628","article-title":"(18)F-FDG PET\/CT in left-ventricular assist device infection: Initial results supporting the usefulness of image-guided therapy","volume":"61","author":"Sommerlath Sohns","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0060","article-title":"CXCR4-targeted imaging of post-infarct myocardial tissue inflammation: Prognostic value after reperfused myocardial infarction","author":"Werner","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0061","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the american heart association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0062","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.7150\/thno.58682","article-title":"Current and future perspectives on functional molecular imaging in nephro-urology: Theranostics on the horizon","volume":"11","author":"Toyama","year":"2021","journal-title":"Theranostics"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0063","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11307-009-0220-5","article-title":"Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[18F]FACBC) with PET in renal carcinoma","volume":"11","author":"Schuster","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0064","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11307-018-1271-2","article-title":"Inconsistent detection of sites of metastatic non-clear cell renal cell carcinoma with PSMA-Targeted [(18)F]DCFPyL PET\/CT","volume":"2","author":"Yin","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13550-016-0231-6","article-title":"Pilot study: Use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour","volume":"6","author":"Rhee","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0066","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00259-020-05165-3","article-title":"18)F-PSMA-1007 PET\/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: Preliminary results","volume":"48","author":"Mittlmeier","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0067","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/cc12529","article-title":"Measurement of kidney perfusion in critically ill patients","volume":"17","author":"Schneider","year":"2013","journal-title":"Crit Care"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0068","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0069","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/0271678X19890931","article-title":"Brain-kidney interaction: Renal dysfunction following ischemic stroke","volume":"40","author":"Zhao","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0070","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients","volume":"48","author":"Giesel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0071","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00259-021-05343-x","article-title":"Value of [(68)Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis","volume":"48","author":"Zhou","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0072","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000474960","article-title":"Fibrotic changes mediating acute kidney injury to chronic kidney disease transition","volume":"137","author":"Oh","year":"2017","journal-title":"Nephron"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0073","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000514913","article-title":"The Role of CXCL12 in kidney diseases: A friend or foe?","volume":"7","author":"Song","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"10.1053\/j.semnuclmed.2021.12.003_bib0074","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","article-title":"Decoding myofibroblast origins in human kidney fibrosis","volume":"589","author":"Kuppe","year":"2021","journal-title":"Nature"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821001045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821001045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:38:39Z","timestamp":1757543919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299821001045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0001299821001045"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.12.003","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPECT and PET Radiotracers in Renal Imaging","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}